Allurion Technologies: Raises $34M in Funding
- The round was led by Novalis LifeSciences and Romulus Capital with participation from IDO Investments and ex-Covidien CEO Jose Almeida
- The financing also includes a growth capital term loan from Bridge Bank
- The Natick-based company previously had raised about $60M between 2013 and its most recent round, a $27M Series C round
- Then the company intends to use the funds to continue growing internationally and, subject to obtaining approval of the U.S. Food and Drug Administration
- The Elipse Balloon received its European Union CE mark in 2015 and is currently available in Europe, the Middle East, and South America
- Allurion says it plans to use the new influx of money to launch the product in the U.S., assuming its approved
